Management of epithelial dermatologic neoplasia

Onkologie

Volumn 21, Issue 1, 1998, Pages 36-43

  Kaufmann, R ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Basal cell carcinoma; Skin cancer; Squamous cell carcinoma; Treatment

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL;

CANCER INCIDENCE; EARLY DIAGNOSIS; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; PHOTODYNAMIC THERAPY; SHORT SURVEY; SKIN CANCER; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE;

EID: 0031900147     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026782     Document Type: Short Survey

References (79)

1. Chuang TY, Popescu A, Su WP, Chute CG: Basal cell carcinoma: A population-based incidence study in Rochester, Minnesota. J Am Acad Dermatol 1990;22:413-417.
2. Gallagher RP, Ma B, Mc Lean DI, Yang CP, Ho V, Carruthers JA, Warshawski LM: Trends in basal cell carcinoma, squamous cell carcinoma, and melanoma of the skin from 1973 through 1987. J Am Acad Dermatol 1990;23:413-421.
3. Ko CB, Walton S, Keczkes K, Bury HPR, Nicholson C: The emerging epidemic of skin cancer. Br J Dermatol 1994;130:269-272.
4. Preston DS, Stern RS: Nonmelanoma cancers of the skin. N Engl J Med 1992,327:1649-1662.
5. Giles GC, Marks R, Foley P: Incidence of non-melanocytic skin cancer treated in Australia. BMJ 1988;296:13-17.
6. Magnus K: The Nordic profile of skin cancer incidence A comparative epidemiological study of the three main types of skin cancer. Int J Cancer 1991; 47:12-19.
7. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: Incidence. J Am Acad Dermatol 1994;30:774-778.
8. Rundel RD: Promotional effects of ultraviolet radiation on human basal and squamous cell carcinoma. Photochem Photobiol 1983;38:569-575.
9. Henriksen T, Dahlback A, Larsen S, Moan J. Ultraviolet-radiation and skin cancer: Effect of an ozone layer depletion. Photochem Photobiol 1990;51: 579-582
10. van Weelden H, de Gruijl FR, van der Putte SCJ, Toonstra J, van der Leun JC. The carcinogenic risk of modern tanning equipment: Is UV-A safer than UV-B? Arch Dermatol Res 1988;280.300-307.
11. Lindelof B, Sigurgersson B, Tegner E, Larko O, Berne B: PUVA and cancer: A large scale epidemiologic study Lancet 1991;338:91-93.
12. Dinehart SM, Chu DZJ, Maners AW, Pollack SV: Immunosuppression in patients with metastatic squamous cell carcinoma from the skin. J Dermatol Surg Oncol 1990,16:271-274.
13. Wang CY, Brodland DG. Su WP Skin cancers associated with acquired immunodeficiency syndrome. Mayo Clinics Proc 1995,70:766-772.
14. Glover MT, Niranjan N, Kwan JT, Leigh IM: Nonmelanoma skin cancer in renal transplant recipients: The extent of the problem and a strategy for management. Br J Plast Surg 1994;47:86-89.
15. Albright SD III: Treatment of skin cancer using multiple modalities J Am Acad Dermatol 1982;7:143-171.
16. Kaufmann R, Landes E: Dermatologische Operationen. 2. Auflage Stuttgart, Thieme, 1992, pp 74-128.
17. Geisse JK: Comparison of treatment modalities for squamous cell carcinoma. Clinics Dermatol 1995; 13:621-626.
18. Fleming ID, Amonette R, Monaghan T, Fleming MD: Principles of management of basal and squamous cell carcinoma of the skin. Cancer 1995;75 (suppl 2):699-704
19. Hacker SM, Browder JF, Ramos-Caro FA: Basal cell carcinoma. Choosing the best method of treatment for a particular lesion. Postgrad Med 1993, 93:101-104.
20. Stern RS, Weinstein MC, Baker SG. Risk reduction for nonmelanoma skin cancer with childhood sunscreen use. Arch Dermatol 1986;122:537-545.
21. Greenberg ER, Baron JA, Stukel TA, Stevens MM, Mandel JS, Spencer SK, Elias PM, Lowe N, Nierenberg DW, Bayrd G. A clinical trial of beta carotene to prevent basal-cell and squamous cell cancers of the skin. The Skin Cancer Prevention Group. N Engl J Med 1990,323:789-795.
22. Cristofolini M, Zumiani G, Scappini P, Piscioli F: Aromatic retinoid in the chemoprevention of the progression of nevoid basal-cell carcinoma syndrome. J Dermatol Surg Oncol 1984;10:778-781.
23. Kraemer KH, DiGiovanna JJ, Moshell AN, Tarone RE, Peck GL: Prevention of skin cancer in xeroderma pigmentosum with use of oral isotretinoin. N Engl J Med 1988;318:1633-1637.
24. Karagas MR, Stukel TA, Greenberg R, Baron JA, Mott LA, Stern RS. Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. JAMA 1992;367:3305-3310.
25. Klein CE, Kaufmann R, Weber L: Leg ulcers and malignancy; in Davy A, Stemmer R (Hrsg): Phlébologie 89. vol I. London. Libbey, 1989, pp 279-281.
26. Callen JP, Bickers DR. Moy RL: Actinic keratosis. J Am Dermatol 1997;36,650-653.
27. Picascia DD, Robinson JK: Actinic cheilitis: A review of the etiology, differential diagnosis, and treatment. J Am Acad Dermatol 1987;17:255-264.
28. Ferrandiz C, Fuente MJ, Ribera M, Bielsa I, Fernandez MT, Lauzurica R, Roca J: Epidermal dysplasia and neoplasia in kidney transplant recipients. J Am Acad Dermatol 1995;33:590-596.
29. Leigh IM, Glover MT: Skin cancer and warts in immunosuppressed renal transplant recipients. Recent Results Cancer Res 1995;139:69-86.
30. Leal-Khouri S, Hruza GJ: Squamous cell carcinoma developing within lichen planus of the penis. Treatment with Mohs' micrographic surgery. J Dermatol Surg Oncol 1994;20:272-276.
31. Bernstein SC, Lim K, Brodland DG, Heidelberg KA: The many faces of squamous cell carcinoma. Dermatol Surg 1996;22:243-254.
32. Kaufmann RH: Intraepithelial neopasia of the vulva Gynecol Oncol 1995;56:8-21.
33. Sturm HM: Bowen's disease and 5-fluorouracil. J Am Acad Dermatol 1979;1:513-522.
34. Abels C, Szeimies RM, Landthaler M: Photodynamische Therapie epithelialer Präkanzerosen und Karzinome, in Garbe C, Dummer R, Kaufmann R, Tilgen W (Hrsg) Dermatologische Onkologie. Berlin, Springer, 1997, pp 120-131.
35. Calzavara-Pinton PG: Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. J Photochem Photobiol 1995;29:53-57.
36. Goldman MP, Fitzpatrick RE: Cutaneous laser surgery. St. Louis, Mosby Year Book Publ., 1994, pp 240-243.
37. Kaufmann R, Hibst R: Clinical evaluation of Er YAG lasers in cutaneous surgery. Lasers Surg Med 1996;19:324-330.
38. Vico P, Fourez T, Nemec E, Andry G, Deraemaecker R: Aggressive basal cell carcinoma of the head and neck. Eur J Surg Oncol 1995;21:490-497
39. Bieley HC, Kirsner RS, Reyer BA, Garland LD. The use of Mohs' micrographic surgery for determination of residual tumour in incompletely excised basal cell carcinoma J Am Acad Dermatol 1992;26:754-756
40. Goldminz D, Bennett RG: Mohs' micrographic surgery of the nail unit. J Dermatol Surg Oncol 1992;18:721-726.
41. Kaufmann R, Sattler G, Vranes M: Das intertriginöse Basaliom, klinische, epidemiologische und therapeutische Aspekte. Z Hautkr 1987;62: 961-968.
42. Kopke LF, Konz B: Mikrographische Chirurgie. Eine methodische Bestandsaufnahme. Hautarzt 1995;46:607-614.
43. Lawrence CM: Mohs' surgery of basal cell carcinoma - A critical review. Br J Plast Surg 1993; 46:599-606.
44. Fratila A, Kaufmann R: Subcutaneously pedicled island flaps. Facial Plast Surg 1997;13:83-92.
45. Kaufmann R: Chemotherapie des Basalioms, in Garbe C, Dummer R, Kaufmann R, Tilgen W (Hrsg) Dermatologische Onkologie. Berlin, Springer, 1997, pp 166-172.
46. von Domarus H, Stevens PJ: Metastatic basal cell carcinoma: Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol 1984;10.1043-1060.
47. Hall VL, Leppard BJ, McGill J, Kesseler ME, White JE, Goodwin P: Treatment of basal-cell carinoma: Comparison of radiotherapy and cryotherapy. Clin Radiol 1986;37:33-34.
48. Edens BL, Bartlow GA, Haghighi P, Astarita RW, Davidson TM: Effectiveness of curettage and electrodesiccation in the removal of basal cell carcinoma J Am Acad Dermatol 1983;9:383-388.
49. Graham GF: Advances in cryosurgery during the past decade Cutis 1993;52:365-372.
50. Wheeland RG, Bailin PL, Ratz JL, Roenigk RK: Carbon dioxide laser vaporization and curettage in the treatment of large or multiple superficial basal cell carcinomas J Dermatol Surg Oncol 1987;13:119-125.
51. Grob JJ, Collet AM, Munoz MH, Bonerandi JJ: Treatment of large basal-cell carcinoma with intralesional interferon-alfa-2a. Lancet 1988.i.878-879.
52. Cornell RC, Greenway HAT. Tucker SB, Edwards L, Ashworth S, Vance JC, Tanner DJ, Taylor EK, Smiles KA, Peets EA: Intralesional interferon therapy for basal cell carcinoma. J Am Acad Dermatol 1990;23:694-700.
53. Dourmishev AL, Popova LI, Dourmishev LA: Basal and squamous cell carcinoma: Sex, age and location distribution: in Altmeyer P, Hoffmann K, Stücker M (eds) Skin Cancer and UV Radiation. Berlin, Springer, 1997, pp 540-546.
54. Weinstock MA: Nonmelanoma skin cancer mortality, in Altmeyer P, Hoffmann K, Stücker M (eds) Skin Cancer and UV Radiation. Berlin, Springer, 1997, pp 534-539.
55. Rowe DE, Carroll RJ, Day CL jr: Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992;26:976-990.
56. Vitaliano PP, Urbach F: The relative importance of risk factors in non-melanoma carcinoma. Arch Dermatol 1980;116:454-456.
57. Breuninger H, Black B, Rassner G: Microstaging of squamous cell carcinomas. Am J Clin Pathol 1990; 94.624-627.
58. Dinehart SM, Pollack SV Metastases from squamous cell carcinoma of the skin and lip: An analysis of twenty-seven cases. J Am Acad Dermatol 1989; 21:241-248.
59. Goepfert H, Dietel WJ, Medina JE, Lindberg RD, Luna MD: Perineural invasion in squamous cell skin carcinoma of the head and neck. Am J Surg 1984; 148:542-547.
60. Breuninger H, Schaumburg-Lever G, Holzschuh J, Horny HP: Desmoplastic squamous cell carcinoma of skin and vermilion surface: A highly malignant subtype of skin cancer. Cancer 1997;79:915-919.
61. Davis MM, Hanke CW, Zollinger TW, Montebello JF, Hornback NB, Norins AL: Skin cancer in patients with chronic radiation dermatitis. J Am Acad Dermatol 1989;20:608-616.
62. Hartevelt MM, Bavinck NJ, Kootte AM, Vermeer BJ, Vanderbroucke JP: Incidence of skin cancer after renal transplantation in the Netherland. Transplantation 1990;49:506-509.
63. LeBoit PE: Is keratoacanthoma a variant of squamous cell carcinoma? New insights into an old controversy . . . soon? Am J Dermatopathol 1995; 17:319-320.
64. Sleater JP, Beers BB, Stephens CA, Hendricks JB: Keratoacanthoma: A deficient squamous cell carcinoma? Study of bcl-2 expression. J Cutan Pathol 1994;21: 514-519.
65. Krunic AL, Garrod DR, Smith NP, Orchard GS, Cvijetic OB: Differential expression of desmosomal glycoproteins in keratoacanthoma and squamous cell carcinoma of the skin: An immunohistochemical aid to diagnosis. Acta Derm Venereol 1996;76:394-398.
66. Netscher DT, Wigoda P, Green LK, Spira M: Keratoacanthoma: When to observe and when to operate and the importance of accurate diagnosis. South Med J 1994;87:1272-1276.
67. Breuninger H: Die operative Therapie des Plattenepithelkarzinoms der Haut; in Garbe C, Dummer R, Kaufmann R, Tilgen W (Hrsg) Dermatologische Onkologie. Berlin, Springer, 1997; pp 201-206.
68. Dzubow LM, Rigel DS, Robins P: Risk factors for local recurrence of primary cutaneous squamous cell carinomas: Treatment by microscopically controlled excision. Arch Dermatol 1982;118:900-902.
69. Geohas J, Roholt NS, Robinson JK: Adjuvant radiotherapy after excision of cutaneous squamous cell carinoma. J Am Acad Dermatol 1994;30:633-636.
70. Levine H: Cutaneous carcinoma of the head and neck: Management of massive and previously uncontrolled lesions. Laryngoscope 1983,93:87-105.
71. Khurana VG, Mentis DH, O'Brien CJ, Hurst TL, Stevens GN, Packham NA: Parotid and neck metastases from cutaneous squamous cell carcinoma of the head and neck. Am J Surg 1995;170:446-450.
72. Kamanabrou D: Systemische Chemotherapie in der Behandlung fortgeschrittener Plattenepithelkarzinome der Haut: in Garbe C, Dummer R, Kaufmann R, Tilgen W (Hrsg) Dermatologische Onkologie. Berlin, Springer, 1997, pp 209-211.
73. Wong WY, Kolbusz RV, Goldberg LH, Guana A: Treatment of a recurrent keratoacanthoma with oral isotretinoin. Int J Dermatol 1994;33:579-583.
74. Hurst LN, Gan BS: Intralesional methotrexate in keratoacanthoma of the nose. Br J Plast Surg 1995;48:243-246.
75. Lippman SM, Parkinson DR, Itri LM, Weber RS, Schantz SP, Ota DM, Schustermann MA, Krakoff IH, Gutterman JU, Hong WK: 13-cis-retinoic acid and interferon alpha-2a: Effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst 1992;84:235-241.
76. Meeuwissen JA, Bourne RG, Kearsley JH: The importance of postoperative radiation therapy in the treatment of Merkel cell carcinoma. Int J Rad Uncol Biol Phys 1995;31:325-331.
77. O'Connor WJ, Brodland DG: Merkel cell carcinoma. Dermatol Surg 1996;22: 262-267.
78. Pectasides D, Moutzourides G, Dimitriadis M, Varthalitis J, Athanassiou A: Chemotherapy for Merkel cell carcinoma with carboplatin and etoposide. Am J Clin Oncol 1995;18:418-420.
79. Fenig E, Lurie H, Sulkes A: The use of cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of Merkel cell carcinoma. Am J Clin Oncol 1993; 16:54-57.